Dynavax Technologies [DVAX] vs Haleon Plc - ADR [HLN] Detailed Stock Comparison

Dynavax Technologies
NASDAQ
Loading...

Haleon Plc - ADR
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Dynavax Technologies wins in 5 metrics, Haleon Plc - ADR wins in 14 metrics, with 0 ties. Haleon Plc - ADR appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Dynavax Technologies | Haleon Plc - ADR | Better |
---|---|---|---|
P/E Ratio (TTM) | 54.60 | 21.82 | Haleon Plc - ADR |
Price-to-Book Ratio | 2.60 | 5.54 | Dynavax Technologies |
Debt-to-Equity Ratio | 58.60 | 53.41 | Haleon Plc - ADR |
PEG Ratio | 0.70 | 23.38 | Dynavax Technologies |
EV/EBITDA | 74.44 | 36.60 | Haleon Plc - ADR |
Profit Margin (TTM) | -16.67% | 13.81% | Haleon Plc - ADR |
Operating Margin (TTM) | 17.45% | 22.21% | Haleon Plc - ADR |
EBITDA Margin (TTM) | 17.45% | 22.21% | Haleon Plc - ADR |
Return on Equity | -9.28% | 9.38% | Haleon Plc - ADR |
Return on Assets (TTM) | 0.52% | 4.61% | Haleon Plc - ADR |
Free Cash Flow (TTM) | $60.16M | $2.68B | Haleon Plc - ADR |
Dividend Yield | N/A | 1.63% | N/A |
1-Year Return | -8.62% | -0.81% | Haleon Plc - ADR |
Price-to-Sales Ratio (TTM) | 4.06 | 4.06 | Haleon Plc - ADR |
Enterprise Value | $959.91M | $129.28B | Haleon Plc - ADR |
EV/Revenue Ratio | 3.04 | 8.72 | Dynavax Technologies |
Gross Profit Margin (TTM) | 85.29% | 55.38% | Dynavax Technologies |
Revenue per Share (TTM) | $3 | $2 | Dynavax Technologies |
Earnings per Share (Diluted) | $-0.45 | $0.45 | Haleon Plc - ADR |
Beta (Stock Volatility) | 1.09 | 0.24 | Haleon Plc - ADR |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Dynavax Technologies vs Haleon Plc - ADR Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Dynavax Technologies | -4.11% | -2.69% | -6.08% | 6.92% | -21.76% | -18.60% |
Haleon Plc - ADR | 0.10% | 1.76% | 1.76% | -11.21% | -3.25% | 4.03% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Dynavax Technologies | -8.62% | -7.08% | 82.93% | -64.72% | -40.00% | -84.54% |
Haleon Plc - ADR | -0.81% | 57.62% | 32.52% | 32.52% | 32.52% | 32.52% |
Performance & Financial Health Analysis: Dynavax Technologies vs Haleon Plc - ADR
Metric | DVAX | HLN |
---|---|---|
Market Information | ||
Market Cap | $1.28B | $44.69B |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 1,899,590 | 7,977,726 |
90 Day Avg. Volume | 1,466,677 | 10,685,552 |
Last Close | $10.50 | $9.82 |
52 Week Range | $9.22 - $14.63 | $8.86 - $11.42 |
% from 52W High | -28.23% | -14.01% |
All-Time High | $106.60 (Nov 27, 2006) | $11.42 (Jun 02, 2025) |
% from All-Time High | -90.15% | -14.01% |
Growth Metrics | ||
Quarterly Revenue Growth | 0.29% | -0.01% |
Quarterly Earnings Growth | 0.64% | 0.33% |
Financial Health | ||
Profit Margin (TTM) | -0.17% | 0.14% |
Operating Margin (TTM) | 0.17% | 0.22% |
Return on Equity (TTM) | -0.09% | 0.09% |
Debt to Equity (MRQ) | 58.60 | 53.41 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | $4.22 | $1.77 |
Cash per Share (MRQ) | $5.23 | $0.08 |
Operating Cash Flow (TTM) | $76.27M | $3.34B |
Levered Free Cash Flow (TTM) | $43.09M | $2.59B |
Dividends | ||
Last 12-Month Dividend Yield | N/A | 1.63% |
Last 12-Month Dividend | N/A | $0.17 |
Valuation & Enterprise Metrics Analysis: Dynavax Technologies vs Haleon Plc - ADR
Metric | DVAX | HLN |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 54.60 | 21.82 |
Forward P/E | 30.42 | 23.38 |
PEG Ratio | 0.70 | 23.38 |
Price to Sales (TTM) | 4.06 | 4.06 |
Price to Book (MRQ) | 2.60 | 5.54 |
Market Capitalization | ||
Market Capitalization | $1.28B | $44.69B |
Enterprise Value | $959.91M | $129.28B |
Enterprise Value Metrics | ||
Enterprise to Revenue | 3.04 | 8.72 |
Enterprise to EBITDA | 74.44 | 36.60 |
Risk & Other Metrics | ||
Beta | 1.09 | 0.24 |
Book Value per Share (MRQ) | $4.22 | $1.77 |
Financial Statements Comparison: Dynavax Technologies vs Haleon Plc - ADR
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | DVAX | HLN |
---|---|---|
Revenue/Sales | $95.44M | $3.71B |
Cost of Goods Sold | $14.04M | $1.66B |
Gross Profit | $81.41M | $2.06B |
Research & Development | $16.62M | $104.93M |
Operating Income (EBIT) | $14.43M | $470.83M |
EBITDA | $24.63M | $486.97M |
Pre-Tax Income | $21.22M | $387.43M |
Income Tax | $2.50M | $88.79M |
Net Income (Profit) | $18.72M | $298.64M |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | DVAX | HLN |
---|---|---|
Cash & Equivalents | $51.72M | $2.97B |
Total Current Assets | $815.97M | $7.73B |
Total Current Liabilities | $68.38M | $7.86B |
Long-Term Debt | $286.03M | $11.65B |
Total Shareholders Equity | $530.94M | $21.94B |
Retained Earnings | $-999.37M | $36.87B |
Property, Plant & Equipment | $64.14M | $0 |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | DVAX | HLN |
---|---|---|
Operating Cash Flow | $-101.66M | N/A |
Capital Expenditures | $-3.93M | N/A |
Free Cash Flow | $-23.57M | N/A |
Debt Repayment | $-80.94M | N/A |
Common Stock Repurchase | $-29.47M | N/A |
Short Interest & Institutional Ownership Analysis
Metric | DVAX | HLN |
---|---|---|
Shares Short | 14.49M | 17.45M |
Short Ratio | 10.94 | 1.39 |
Short % of Float | 0.19% | 0.00% |
Average Daily Volume (10 Day) | 1,899,590 | 7,977,726 |
Average Daily Volume (90 Day) | 1,466,677 | 10,685,552 |
Shares Outstanding | 125.45M | 12.27B |
Float Shares | 98.91M | 8.95B |
% Held by Insiders | 0.01% | 0.00% |
% Held by Institutions | 0.99% | 0.13% |
Dividend Analysis & Yield Comparison: Dynavax Technologies vs Haleon Plc - ADR
Metric | DVAX | HLN |
---|---|---|
Last 12-Month Dividend | N/A | $0.17 |
Last 12-Month Dividend Yield | N/A | 1.63% |
3-Year Avg Annual Dividend | N/A | $0.11 |
3-Year Avg Dividend Yield | N/A | 0.91% |
3-Year Total Dividends | N/A | $0.34 |
Ex-Dividend Date | N/A | Apr 25, 2025 |